Table 1 Clinical information of each ECM cluster in TCGA-BRCA cohort
| Â | Level | C1 | C2 | C3 | P |
|---|---|---|---|---|---|
n | Â | 458 | 367 | 201 | Â |
Subtype (%) | Basal | 1 (0.2) | 69 (18.8) | 112 (55.7) | < 0.001 |
Her2 | 0 (0.0) | 50 (13.6) | 24 (11.9) | Â | |
LumA | 370 (80.8) | 138 (37.6) | 29 (14.4) | Â | |
LumB | 77 (16.8) | 97 (26.4) | 20 (10.0) | Â | |
Normal | 10 (2.2) | 13 (3.5) | 16 (8.0) | Â | |
T_stage (%) | T1 | 141 (30.8) | 90 (24.5) | 48 (23.9) | 0.001 |
T2 | 242 (52.8) | 240 (65.4) | 131 (65.2) | Â | |
T3 | 75 (16.4) | 37 (10.1) | 22 (10.9) | Â | |
N_stage (%) | LN_Negative | 224 (49.6) | 161 (44.7) | 109 (55.1) | 0.061 |
LN_Positive | 228 (50.4) | 199 (55.3) | 89 (44.9) | Â | |
Age (%) | < = 35 | 7 (1.5) | 15 (4.1) | 11 (5.5) | 0.003 |
> = 60 | 235 (51.3) | 161 (43.9) | 78 (38.8) |  | |
35 ~ 60 | 216 (47.2) | 191 (52.0) | 112 (55.7) |  |